Ying Qin

Neutrophils as Emerging Immunotherapeutic Targets: Indirect Treatment of Tumors by Regulating the Tumor Immune Environment Based on a Sialic Acid Derivative-Modified Nanocomplex Platform

Mengyang Liu, Xinrong Liu, Yanzhi Song, 2022, International journal of pharmaceutics.

The Fate of Sialic Acid and PEG Modified Epirubicin Liposomes in Aged versus Young Cells and Tumor Mice Models

Xinrong Liu, Yanzhi Song, Yihui Deng, 2022, Pharmaceutics.

Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity.

Xinrong Liu, Yanzhi Song, Yihui Deng, 2021, International journal of pharmaceutics.